Using p62 for treatment and prevention of wounds.

WO2026019549A1PCT designated stage Publication Date: 2026-01-22CURELAB ONCOLOGY INC
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
PCT/US2025/035558
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-06-26
Filing Date
2025-06-26
Publication Date
2026-01-22

Smart Images

  • Figure IMGF000013_0001
    Figure IMGF000013_0001
  • Figure IMGF000014_0001
    Figure IMGF000014_0001
  • Figure IMGF000015_0001
    Figure IMGF000015_0001
Patent Text Reader

Abstract

Methods, substances, and compositions of matter for using SQSTM1 / p62 (sequestosome 1) protein or encoding nucleic acid for wound treatment are provided.
Need to check novelty before this filing date? Find Prior Art

Description

[0001]- . . , , ,, , . . ’ . .. . , . , ,, . . - . . , , , ae o. - . . . , . . , — - , — — , , ,, , .— , , — . , , , — ,, ,, , . . .. , ,,, . . ae o - .. , ,. . , – , . - . , . , . ’ , , . . . , , , , , , , ’ ,- , . , . . , , , , - . , ,, ae o - , , , . , ., , , , , , , ., . , . , ,. , - . . . , . , , , , ,. . , .. , , , , ,, . ., , , , , ., . ae o - , , ., , ,, , , , , .. -. , ,, , . . , ,, ,. , , . ’ -. - , , , , .. . , ’ .- , . , . - . . ,, . , ae o - ,. . ,, . , . . - .. , , , ., .,- , , , - . . , . . . , - , , , , . , . . - ,, , ae o -. , , , ,‑ . ,, , . , , - . , , , “ ” , . , , , , .., . , . .‐, , , ‐ . ,‐ . , . , ,‐ . ‐ , , , , .‐ , ‐ ‐,‐,‐ ‐ , . , , , ‐ ., ae o - . , . . . . . - - .. . – . . . . . – ., , – , — ae o - , , — , ,. . ,. - , . .,, - , , ,2, , –2., . ,– . ,.. . , , , , . ,. - ,. . , . .. , . . ae o - .. - . . —, , . . , - . 2 ,, ., . , , . , -. , , .st, , , , , . , -.- .. , . . , ’ ae o , - - - . . , . , . - ,° . . , , . . . , ., . , , , , . – .. . . , . - . , ° , , . , , , — . . - — . ae o - ,. ,- . °. , . . , - . ,, - - . – , - . . . . ... , , , . , - . , . , . . , . . . — — . — . - .... .... .... . . , .. . , – ,.. , , ,. . , . . ae o - ,. . , . . . ae o . - . ,. , . .. , . . ,,- . , – , - . . , , , , ., . ., . . , ., . , . , . . , , - .., , . . . . ae o - , , ,. . - , , , . , , - , ..., , , , , , , . , . , . - , , , . - . , - ae o - . , , . , - , ,. - , . . ,, , - . . , . , - , , ,- . . , , , .., ,, , . , , , -. . , . - , , . , - . ae o - . , , . , - ,-,., . . . , , , - . . , . , -, , , , . , , ..,, ,, -, , ,. . , - , ,. . - , , - . . , , ae o - . , . -, , . -, . , , , - . . , . , -, , , .,. , - , ,.., , , , , ., , . , - . . - , , , ., - ., ,, . ae o - . , . --, , , . .,., ,, - . , . , . ,-, , - ..., , - , -, , , , , , . , . , - -, ,., - . - - , ., , . ae o - . , - -, . , . - , . , , - , - . . - , . , , , , , -. . , , , , .., , ., , , . , - . - , ,., -. ,. ,, . ae o - . , . - , , . -, . , , . , - . . - , . , , , , . , - . .., , , , , , . , , , . , - ,., , . - ,. ,, - . ae o - . , . --, , , . . . , , , - . , , . - , . , , , , , , ..,. ,, - , , , , , ., , , -. , , ,., , , . - . , ae o - - . , , . , , - , ,. -, , . . , , , , - . ae o

Claims

.., ,

Citation Information

Patent Citations

  • Methods and Compositions Relating to p62 / SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases

    US20220009985A1